Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Enzastaurin in Follicular Lymphoma
2007-006246-17Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of enzastaurin in follicular lymphoma (FL) and mature B-cell lymphoma, sponsored by Eli Lilly and Company. Primary endpoint: Tumor response rate. Started Apr 2008; status: completed.
02
Drugs
enzastaurin
03
Conditions
follicular lymphoma (FL)mature B-cell lymphoma
Beyond the preview
Go deeper on 2007-006246-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006246-17.